1. Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1
    Deborah Fanfone et al, 2017, Med Oncol CrossRef
  2. Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas
    Nadège Kindt et al, 2017, IJMS CrossRef
  3. Histological Mapping and Subtype-Specific Functions of Galectins in Health and Disease
    Junko Nio-Kobayashi, 2018, Trends in Glycoscience and Glycotechnology CrossRef
  4. The Role of Galectins in Cervical Cancer Biology and Progression
    Lufang Wang et al, 2018, BioMed Research International CrossRef
  5. Galectin-1 Restricts Vascular Smooth Muscle Cell Motility Via Modulating Adhesion Force and Focal Adhesion Dynamics
    Min-Shao Tsai et al, 2018, Sci Rep CrossRef
  6. Upregulation of LGALS1 is associated with oral cancer metastasis
    Ji-Min Li et al, 2018, Ther Adv Med Oncol CrossRef
  7. null
    Ilze Fridrihsone et al, 2018 CrossRef
  8. Current and future markers for the diagnosis of thyroid cancer
    DESCAMPS Géraldine et al, 2019, COR CrossRef
  9. An amperometric biosensor based on Cu2O@Au nanocomposites for the detection of galectin-1 via lactose–galectin interactions
    Feng Long et al, 2019, Nanotechnology CrossRef
  10. Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes
    Deborah Fanfone et al, 2020, Biology CrossRef

  11. The Blood Biomarkers of Thyroid Cancer


    Weiran Wang et al, 2020, CMAR CrossRef
  12. The Extracellular Matrix-Derived Biomarkers for Diagnosis, Prognosis, and Personalized Therapy of Malignant Tumors
    Elena V. Petersen et al, 2020, Front. Oncol. CrossRef
  13. New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer
    Laetitia Gheysen et al, 2021, Cells CrossRef
  14. CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
    Xin Wang et al, 2021, Aging CrossRef
  15. Galectin-9 as a biomarker of disease severity.
    Preeti Moar et al, 2021, Cell Immunol CrossRef
  16. Inhibition of galectins in cancer: Biological challenges for their clinical application
    Diego José Laderach et al, 2023, Front. Immunol. CrossRef
  17. Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies
    Nikiforos-Ioannis Kapetanakis et al, 2023, Front. Immunol. CrossRef
  18. The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer
    Nerina Denaro et al, 2023, Cancers CrossRef
  19. Altered profile of glycosylated proteins in serum samples obtained from patients with Hashimoto′s thyroiditis following depletion of highly abundant proteins
    Yaozheng Xu et al, 2023, Front. Immunol. CrossRef
  20. LGALS1 regulates cell adhesion to promote the progression of ovarian cancer
    Xuejian Li et al, 2023, Oncol Lett CrossRef
  21. Galectin-9 is a target for the treatment of cancer: A patent review
    Cássia Ferreira Rodrigues et al, 2023, International Journal of Biological Macromolecules CrossRef
  22. Immunomodulation exerted by galectins: a land of opportunity in rare cancers
    Laura Díaz-Alvarez et al, 2023, Front. Immunol. CrossRef
  23. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis
    Haotian Liu et al, 2023, Hematology CrossRef
  24. Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer
    Susana Torres-Martínez et al, 2023, IJMS CrossRef
  25. The Evaluation of Glyceryl C3‐Azolyl‐Thiogalactosides as Galectin‐1 and Galectin‐3 Ligands
    Vít Prouza et al, 2025, ChemMedChem CrossRef